Name: solid phase synthesis of a functionalized bis-peptide using "safety catch" methodology
Uploaded: 2012-05-15T13:00:00
Duration: 11 min 42 s
Description: Watch this Scientific Journal Video about Solid Phase Synthesis of a Functionalized Bis-Peptide Using "Safety Catch" Methodology at JoVE.com

The authors would like to thank Dr. Zachary Z. Brown and Jennifer Alleva for the initial development of this solid phase synthesis technique and Matthew F.L. Parker for helpful discussions. This work is supported by the Defense Threat Reduction Agency (DOD-DTRA) (HDTRA1-09-1-0009) and the Horst Witzel Fellowship Award supported by Cephalon, Inc.

1. Setup
<ol>
 <li>The reaction set-up for the solid-phase synthesis is a polypropylene filter cartridge or glass reactor that is connected via polypropylene tubing to an enclosed filtering flask under vacuum as shown in Figure 1. The reaction can be mixed by a magnetic stir bar or by bubbling nitrogen through the reactor.</li>
 <li>A gas manifold connected to an Argon cylinder equipped with a drying tube and oil bubbler is also recommended as it allows the reaction vessel to be contained under an inert atmosphere and allows the removal of reagents from sealed containers.</li>
 <li>All operations are performed in a fume hood and proper personal protective equipment (safety glasses, lab coat and nitrile gloves) is required.</li>
</ol>
2. Loading First Bis-Peptide Onto Resin
<ol>
 <li>Weigh 114 mg of HMBA-AM Resin (0.88 mmol / g loading, 100 &mu;mol) into 8 mL reaction vessel and add magnetic stir bar. Cap the top of the vessel with a rubber septum and purge the tube with argon for at least 5 minutes.</li>
 <li>In the meantime, weigh 117.3 mg of compound 1 of Figure 3 (586.63 g / mol, 2eq) and 59.2 mg of 1-(mesitylene-2-sulfonyl)-3-nitro-1,2,4-triazole (MSNT, 296.0 g / mol, 2eq) into a 15 mL disposable centrifuge tube and dissolve in 2 mL anhydrous dichloromethane (DCM). Add 24 &mu;L of 1-methylimidazole (NMI, 80.81 mL / mol, 3eq) to solution and mix until completely dissolved.</li>
 <li>Transfer the activated solution to the reaction vessel via syringe and allow to stir under argon overnight (~10 hours).</li>
 <li>Remove the septum and drain the reaction mixture. Wash the resin with DCM (5x) and dimethylformamide (DMF) (5x). Perform the "methyl red test" described in section 10.1 to assess the degree of resin loading. If the resin remains red during the methyl red test then steps 2.2 and 2.3 should be repeated. A yellow color, indicative of a negative methyl red test, is preferred; however, since any remaining hydroxyl groups will be capped in the next step, a slightly positive result (light orange resin color) may be acceptable.</li>
</ol>

3. Deprotection of First Bis-Peptide and Simultaneous Resin Capping
<ol>
 <li>Add 1 mL of DCM to the reaction vessel then add 1 mL 33% hydrogen bromide in acetic acid dropwise over 30 seconds (bubbling occurs) and allow to stir for 15 minutes. Drain and wash the resin with DCM (5x) then repeat process once more.</li>
 <li>Wash the resin with DCM (5x) then DMF (5x). Neutralize the resin by washing twice with a 5% v/v solution of N,N-diisopropylethylamine (DIPEA) in DMF then wash with DCM (5x) and DMF (5x) again. Perform the "methyl red test" and "chloranil test" discussed in section 10.1 and 10.2. Results should be negative for the methyl red test and positive for the chloranil test.</li>
</ol>
4. Coupling Boc/tBu-Protected Functionalized Bis-Amino Acid
<ol>
 <li>Reintroduce an inert atmosphere to the resin-containing reaction vessel by washing three times with anhydrous DCM then attach a septum and argon line. Purge and wash the vessel by adding 1-2 mL of anhydrous DCM and letting stir for 30 seconds then draining the vessel until the argon line bubbler begins to rise. Do this at least once more.</li>
 <li>Prepare a solution of 0.15 M functionalized bis-amino acid (3eq) and 245 mg of 1-hydroxy-7-azabenzotriazole (HOAt, 136.11 g / mol, 18eq) in 2 mL of 2:1 DCM:DMF in a flame dried test tube under argon atmosphere. Add 47 &mu;L of diisopropylcarbodiimide (DIC, 156.6 mL / mol, 3eq) and stir for 90 minutes.</li>
 <li>Add 35 &mu;L DIPEA (174.19 mL / mol, 2eq) in 666 &mu;L anhydrous DMF to resin and allow to stir for 5 minutes.</li>
 <li>Transfer the pre-activated bis-amino acid solution to reaction vessel via syringe and allow to stir overnight.</li>
 <li>Drain the reaction mixture and wash twice with anhydrous DCM while under argon.</li>
 <li>To promote the closure of the diketopiperazine, add a 0.25 M solution of HOAt (136.11 g / mol, 10eq) and DIC (156.6 mL / mol, 10eq) in a 4 mL of 1:1 DCM:DMF and allow to stir under argon for 1 hour.</li>
 <li>Remove the septum and drain the reaction mixture. Wash the resin with DCM (5x) and DMF (5x). If desired, perform the "chloranil test" discussed in section 10.2.</li>
</ol>
5. Deprotection of Boc/tBu-Protected Functionalized Bis-Amino Acid
<ol>
 <li>Add 2 mL of a solution of 95:5 trifluororacetic acid (TFA):triisopropylsilane (TIPS) to the reaction vessel and allow it to stir for 1 hour. Drain and wash the resin for about 30 seconds with DCM (5x) then repeat process once more.</li>
 <li>Wash the resin with DCM (5x) then DMF (5x). Neutralize the resin by washing twice with a 5%v/v solution of DIPEA in DMF then wash DCM (5x) and DMF (5x) again. If desired, perform the "chloranil test" discussed in section 10.2.</li>
</ol>
6. Repeat steps 4 and 5 as desired to synthesize targeted bis-peptide.
7. Functionalizing the Bis-Peptide Prolidine End
<ol>
 <li>The prolidine end of the growing bis-peptide may be acylated independently or together through a diketopiperazine. Also, this end can be left protected, which will be cleaved latter, affording the free amino acid. If desired, perform the "chloranil test" discussed in section 10.2 to assess coupling efficiency.</li>
</ol>
8. Deprotection of Fmoc and Acylation of the Quaternary End of the Bis-Peptide
<ol>
 <li>A 2mL solution of 20% piperidine in DMF is added and the reaction is mixed for 20 minutes. Drain and wash the resin with DMF (5x) then repeat process once more.</li>
 <li>Wash the resin with DCM (5x) then DMF (5x).</li>
 <li>Prepare a 0.15 M solution of amino acid (3eq) in 2 mL of N-methylpyrrolidone (NMP) with 114 mg 2-(7-aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU, 380.2 g / mol, 3eq) and 104.5 &mu;L DIPEA (174.19 mL / mol, 6eq) and mix well. Add to reaction vessel and allow to stir for 6 hours.</li>
 <li>Wash the resin with DCM (5x) then DMF (5x).</li>
</ol>
9. Remove the Boc Group from the Resin Bound Amino Acid and Cleave from Resin
<ol>
 <li>Add 2 mL of a 1:1 TFA:DCM solution to the reaction vessel and allow to stir for 30 minutes. Drain and wash the resin with DCM (5x) then repeat process once more.</li>
 <li>Wash and drain the resin for 30 seconds with DCM (5x) then DMF (5x).</li>
 <li>Add 2 mL of a solution of 10% DIPEA in anhydrous DMF and allow to stir 24-48 hours.</li>
 <li>Collect reaction mixture into pre-weighed round bottom flask. Transfer 30 &mu;L of this solution to 450 &mu;L of THF in an LC-MS vial and submit for analysis. Wash the resin with additional aliquots of DMF and collect into the round bottom flask then remove solvent in vacuo.</li>
</ol>

10. Purification of Bis-Peptide
<ol>
 <li>Dissolve crude bis-peptide in a minimal amount of dimethyl sulfoxide (100-250 &mu;L) and transfer into HPLC vial insert. Place insert into autosampler of semi-prepitive HPLC system (Hewlett Packard 1100 Series) equipped with an XTerra Prep MS C18 5 &mu;m 7.8x150 mm column and a 100 &mu;L injection loop.</li>
 <li>Perform multiple 50 &mu;L injections of the sample using a gradient program of 5-95% acetonitrile in water with 0.1% formic acid over 30 minutes while monitoring at 274 nm. Collect the product peak in a pre-weighed disposable centrifuge tube and freeze dry using a lyophilizer. Caution should be taken with the first run as a slight shift in peak retention time compared to analytical LCMS is typically observed.</li>
</ol>

11. Assessment Methods
<ol>
 <li>METHYL RED TEST7: Remove ~1 mg of dry resin via disposable pipette and rinse into 4 mL reaction vessel. Add a solution of 20 mg methyl red, 50 &mu;L N,N'-diisopropylcarbodiimide (DIC), and 5 mg 4-dimethylaminopyridine (DMAP) in 500 &mu;L anhydrous DCM and allow to stir for 5-10 min. Drain and wash resin with DCM until the filtrate becomes colorless. Positive indication is the resin beads remaining orange or red.</li>
 <li>CHLORANIL TEST12: Transfer ~1 mg of dry resin into a small vial via disposable pipette. Add 3 drops of both a 0.8 mM chloranil in DMF solution and 2% acetaldehyde in DMF solution and let sit at room temperature for 5-10 minutes. Positive indication is the resin beads turning blue/purple.</li>
 <li>ACTIVATION TRAP TEST: Activated compounds during the synthesis can be assessed by transferring a small amount (5-10 &mu;L) of the activated solution to a liquid chromatography-mass spectrometry (LC-MS) vial containing 50 &mu;L of pyrrolidine. Mix by hand for a few seconds (solution should become yellow) then dilute with 450 &mu;L of tetrahydrofuran (THF) and submit for LC-MS analysis.</li>
 <li>ANALYTICAL LC-MS: The final product and activated intermediates can be assessed using an HP 1200 series LC-MS system equipped with a Waters Xterra MS C18 3.5 &mu;m 4.6 mm x 150 mm column and a gradient system of 5-95% acetonitrile in water with 0.1% formic acid over 30 minutes.</li>
</ol>
12. Representative Results
An example of both crude (Figure 4) and purified (Figure 5) LCMS traces are provided. Purified yields of approximately 10% are expected using the methods outlined above.
<img alt="Figure 1" src="/files/ftp_upload/4112/4112fig1.jpg" /> 
Figure 1. Diagram of Experimental Set-Up for Solid Phase Synthesis.
<img alt="Figure 2" src="/files/ftp_upload/4112/4112fig2.jpg" /> 
Figure 2. Relevant Nomenclature of Bis-Amino Acids/Bis-Peptides.
<img alt="Figure 3" src="/files/ftp_upload/4112/4112fig3.jpg" /> 
Figure 3. Overall Synthetic Scheme. <a href="https://www.jove.com/files/ftp_upload/4112/4112fig3large.jpg" target="_blank"> Click here to view larger figure</a>.
<img alt="Figure 4a" src="/files/ftp_upload/4112/4112fig4a.jpg" /> 
Figure 4a. HPLC Trace of Crude Product at 274 nm.
<img alt="Figure 4b" src="/files/ftp_upload/4112/4112fig4b.jpg" /> 
Figure 4b. MS Spectrum of Crude Product Peak.
<img alt="Figure 5a" src="/files/ftp_upload/4112/4112fig5a.jpg" /> 
Figure 5a. HPLC Trace of Purified Product at 274 nm.
<img alt="Figure 5b" src="/files/ftp_upload/4112/4112fig5b.jpg" /> 
Figure 5b. MS Spectrum of Purified Product Peak.

<ol>
	<li>Atherton, E., Sheppard, R. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> Solid Phase Peptide Synthesis: A Practical Approach. , (1989).</li><li>Brown, Z. Z., Alleva, J., Schafmeister, C. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Solid-Phase+Synthesis+of+Functionalized+Bis-Peptides.">Solid-Phase Synthesis of Functionalized Bis-Peptides.</a> Biopolymers. 96, 578-585 (2010).</li><li>Schafmeister, C. E., Brown, Z. Z., Gupta, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Shape-Programmable+Macromolecules.">Shape-Programmable Macromolecules.</a> Acc. Chem. Res. 41, 1387-1398 (2008).</li><li>Brown, Z. Z., Schafmeister, C. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Synthesis+of+Hexa-+and+Pentasubstituted+Diketopiperazines+from+Sterically+Hindered+Amino+Acids.">Synthesis of Hexa- and Pentasubstituted Diketopiperazines from Sterically Hindered Amino Acids.</a> Org. Let. 12, 1436-1439 (2010).</li><li>Nielson, J., Lyngso, L. O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Combinatorial+Solid-Phase+Synthesis+of+Balanol+Analogues.">Combinatorial Solid-Phase Synthesis of Balanol Analogues.</a> Tet. Lett. 37, 8439-8442 (1996).</li><li>Blankemeyer-Menge, B., Nimtz, M., Frank, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=An+Efficient+Method+for+Anchoring+Fmoc-Amino+Acids+to+Hydroxyl-Functionalized+Solid+Supports.">An Efficient Method for Anchoring Fmoc-Amino Acids to Hydroxyl-Functionalized Solid Supports.</a> Tet. Lett. 31, 1701-1704 (1990).</li><li>Komba, S., Sasaki, S., Machida, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+New+Colorimetric+Test+for+Detection+of+Hydroxyl+Groups+in+Solid-Phase+Synthesis.">A New Colorimetric Test for Detection of Hydroxyl Groups in Solid-Phase Synthesis.</a> Tet. Lett. 48, 2075-2078 (2007).</li><li>Demner, O., Dijkgraaf, I., Schottelius, M., Wester, H. J., Kessler, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Introduction+of+Functional+Groups+into+Peptides+via+N-Alkylation.">Introduction of Functional Groups into Peptides via N-Alkylation.</a> Org. Lett. 10, 2015-2018 (2008).</li><li>Plas, S. E. V. a. n. d. e. r., Van Hoeck, E., Lynen, F., Sandra, P., Madder, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Toward+a+New+SPE+Material+for+EDCs:+Fully+Automated+Synthesis+of+a+Library+of+Tripodal+Receptors+Followed+by+Fast+Screening+by+Affinity+LC.">Toward a New SPE Material for EDCs: Fully Automated Synthesis of a Library of Tripodal Receptors Followed by Fast Screening by Affinity LC.</a> Eur. J. Org. Chem. 11, 1796-1805 (2009).</li><li>Kaiser, E., Colescot, R. L., Bossinger, C. D., Cook, P. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Color+Test+for+Detection+of+Free+Terminal+Amino+Groups+in+Solid-Phase+Synthesis+of+Peptides.">Color Test for Detection of Free Terminal Amino Groups in Solid-Phase Synthesis of Peptides.</a> Anal. Biochem. 34, 595-598 (1970).</li><li>Chan, W. C., White, P. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> Fmoc Solid Phase Peptide Synthesis: A Practical Approach. , (2000).</li><li>Vojkovsky, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Detection+of+Secondary+Amines+on+Solid-Phase.">Detection of Secondary Amines on Solid-Phase.</a> Peptide Research. 71, 236-237 (1995).</li></ol>

Production and Free Access to this article is sponsored by the United States Defense Threat Reduction Agency.

The synthetic approach presented herein provides a method for the synthesis of functionalized bis-peptides from bis-amino acid building blocks using common solid-phase peptide synthesis techniques. The monomer synthesis of these "Pro4" building blocks from trans-4-hydroxyproline3 is highly scalable and has been successfully completed to the hydantoin stage at a 600 mmol (234 g) scale (unpublished). Once the monomers are in hand, the use of solid-phase techniques provides a more rapid method of bis-peptide synthesis than our current solution-phase methodology4 by eliminating the need for reaction work-ups and intermediate purifications. 
The primary challenge in solid-phase synthesis is diagnosing synthetic progress and problem solving since no intermediates are isolated. This has lead to the development of many colorimetric tests including those to identify if free amines (Kaiser Test10) or free hydroxyls (Methyl Red Test7) are exposed on resin. Unfortunately, the commonly used Kaiser Test10 is not generally applicable in our solid-phase synthesis due to the almost exclusive use of secondary amines or amines attached to a quaternary carbon. Other options for assessment on HMBA resin include test cleavages using a nucleophile such as hydrazine11, quantitative Fmoc cleavage monitored by UV/Vis1,11, and trapping and analyzing incoming activated compounds. 
Another overlooked issue in solid-phase synthesis is the repetitive nature of synthetic steps required by the operator. With this is mind, the authors strongly recommend the use of a spreadsheet or checklist when performing any manual solid-phase peptide synthesis.
The difficultly in using bis-peptides for solid-phase synthesis compared to common &alpha;-amino acids includes the potential for more difficult couplings due to steric hindrance, the need for on-resin diketopiperazine closures, and simultaneous deprotections (Boc/tBu; Cbz/tBu). Another difficultly lies in achieving quantitative release from the resin using this "safety catch" method when compared to more conventional means. With these factors in mind, it is very possible that further optimization of this method can be achieved and current efforts are underway in our group to improve the method presented here.

<table border="1">
 <tr>
 <td>Name</td>
 <td>Company</td>
 <td>Catalogue Number</td>
 <td>Comments</td>
 </tr>
 <tr>
 <td>HMBA-Am Resin</td>
 <td>NovaBiochem</td>
 <td>855018</td>
 <td>&nbsp;</td>
 </tr>
 <tr>
 <td>MSNT</td>
 <td>NovaBiochem</td>
 <td>851011</td>
 <td>&nbsp;</td>
 </tr>
 <tr>
 <td>NMI</td>
 <td>Sigma-Aldrich</td>
 <td>336092</td>
 <td>Toxic, Corrosive</td>
 </tr>
 <tr>
 <td>DCM</td>
 <td>Sigma-Aldrich</td>
 <td><a href="http://www.sigmaaldrich.com/catalog/ProductDetail.do?lang=en&amp;N4=D65100%7CSIAL&amp;N5=SEARCH_CONCAT_PNO%7CBRAND_KEY&amp;F=SPEC" target="_blank">D65100</a></td>
 <td>Carcinogenic</td>
 </tr>
 <tr>
 <td>Anhydrous DCM</td>
 <td>Acros</td>
 <td>34846</td>
 <td>Carcinogenic</td>
 </tr>
 <tr>
 <td>33% Hydrogen Bromide in Acetic Acid</td>
 <td>Sigma-Aldrich</td>
 <td>248630</td>
 <td>Toxic, Corrosive, Fumes when open</td>
 </tr>
 <tr>
 <td>DIPEA</td>
 <td>Sigma-Aldrich</td>
 <td>387649</td>
 <td>Flammable, Toxic, Corrosive</td>
 </tr>
 <tr>
 <td>DMF</td>
 <td>Fisher Scientific</td>
 <td>AC27960</td>
 <td>Flammable, Toxic</td>
 </tr>
 <tr>
 <td>Anhydrous DMF</td>
 <td>Acros</td>
 <td>34843</td>
 <td>Flammable, Toxic</td>
 </tr>
 <tr>
 <td>HOAt</td>
 <td>GenScript</td>
 <td>C01568</td>
 <td>&nbsp;</td>
 </tr>
 <tr>
 <td>DIC</td>
 <td>Acros</td>
 <td>BP590</td>
 <td>Flammable, Toxic, Corrosive</td>
 </tr>
 <tr>
 <td>TFA</td>
 <td>Sigma-Aldrich</td>
 <td>T6508</td>
 <td>Toxic, Corrosive</td>
 </tr>
 <tr>
 <td>TIPS</td>
 <td>Acros</td>
 <td>21492</td>
 <td>Flammable, Toxic</td>
 </tr>
 <tr>
 <td>Piperidine</td>
 <td>Sigma-Aldrich</td>
 <td>104094</td>
 <td>Flammable, Toxic, Corrosive</td>
 </tr>
 <tr>
 <td>HATU</td>
 <td>GenScript</td>
 <td>C01566</td>
 <td>Toxic</td>
 </tr>
 <tr>
 <td>NMP</td>
 <td>Acros</td>
 <td>36438</td>
 <td>Toxic</td>
 </tr>
 <tr>
 <td>DMAP</td>
 <td>NovaBiochem</td>
 <td>851055</td>
 <td>Toxic</td>
 </tr>
 <tr>
 <td>Methyl Red</td>
 <td>Sigma-Aldrich</td>
 <td>250198</td>
 <td>&nbsp;</td>
 </tr>
 <tr>
 <td>THF</td>
 <td>Sigma-Aldrich</td>
 <td>401757</td>
 <td>Flammable, Toxic, Peroxide Forming</td>
 </tr>
 <tr>
 <td>Pyrrolidine</td>
 <td>Sigma-Aldrich</td>
 <td>P73803</td>
 <td>Flammable, Toxic, Corrosive</td>
 </tr>
 <tr>
 <td>Dimethyl Sulfoxide</td>
 <td>Fisher</td>
 <td>D1281</td>
 <td>&nbsp;</td>
 </tr>
 <tr>
 <td>SPPS Reaction Vessels</td>
 <td>Grace</td>
 <td>211108</td>
 <td>&nbsp;</td>
 </tr>
 <tr>
 <td>LCMS</td>
 <td>Agilent</td>
 <td>1200 Series</td>
 <td>&nbsp;</td>
 </tr>
 <tr>
 <td>Semi-Prep LC</td>
 <td>Hewlett Packard</td>
 <td>1100 Series</td>
 <td>&nbsp;</td>
 </tr>
 <tr>
 <td>Lyophilizer</td>
 <td>Labconco</td>
 <td>7934027</td>
 <td>&nbsp;</td>
 </tr>
 <tr>
 <td>Rotovapor</td>
 <td>Buchi</td>
 <td>R-210 Series</td>
 <td>&nbsp;</td>
 </tr>
 <tr>
 <td>Argon</td>
 <td>Airgas</td>
 <td>AR PP300CT</td>
 <td>&nbsp;</td>
 </tr>
</table>

solid phase synthesis of a functionalized bis-peptide using "safety catch" methodology

In 1962, R.B. Merrifield published the first procedure using solid-phase peptide synthesis as a novel route to efficiently synthesize peptides. This technique quickly proved advantageous over its solution-phase predecessor in both time and labor. Improvements concerning the nature of solid support, the protecting groups employed and the coupling methods employed over the last five decades have only increased the usefulness of Merrifield's original system. Today, use of a Boc-based protection and base/nucleophile cleavable resin strategy or Fmoc-based protection and acidic cleavable resin strategy, pioneered by R.C. Sheppard, are most commonly used for the synthesis of peptides1.
Inspired by Merrifield's solid supported strategy, we have developed a Boc/tert-butyl solid-phase synthesis strategy for the assembly of functionalized bis-peptides2, which is described herein. The use of solid-phase synthesis compared to solution-phase methodology is not only advantageous in both time and labor as described by Merrifield1, but also allows greater ease in the synthesis of bis-peptide libraries. The synthesis that we demonstrate here incorporates a final cleavage stage that uses a two-step "safety catch" mechanism to release the functionalized bis-peptide from the resin by diketopiperazine formation.
Bis-peptides are rigid, spiro-ladder oligomers of bis-amino acids that are able to position functionality in a predictable and designable way, controlled by the type and stereochemistry of the monomeric units and the connectivity between each monomer. Each bis-amino acid is a stereochemically pure, cyclic scaffold that contains two amino acids (a carboxylic acid with an &alpha;-amine)3,4. Our laboratory is currently investigating the potential of functional bis-peptides across a wide variety of fields including catalysis, protein-protein interactions and nanomaterials.

Watch this Scientific Journal Video about Solid Phase Synthesis of a Functionalized Bis-Peptide Using "Safety Catch" Methodology at JoVE.com

Solid Phase Synthesis of a Functionalized Bis-Peptide Using &quot;Safety Catch&quot; Methodology

The efficient solid-phase peptide synthesis of a functionalized bis-peptide trimer utilizing a "safety catch" cleavage procedure from HMBA resin is described.

Solid Phase Synthesis of a Functionalized Bis-Peptide Using "Safety Catch" Methodology

In 1962, R.B. Merrifield published the first procedure using solid-phase peptide synthesis as a novel route to efficiently synthesize peptides. This ...

solid-phase-synthesis-functionalized-bis-peptide-using-safety-catch

Research

JoVE Journal

Biology

Measuring Caenorhabditis elegans Life Span on Solid Media

Aging is a degenerative process characterized by a progressive deterioration of cellular components and organelles resulting in mortality. The nematode Caenorhabditis elegans has emerged as a principal model used to study the biology of aging. Because virtually every biological subsystem undergoes functional decline with increasing age, life span is the primary endpoint of interest when considering total rate of aging. In nematodes, life span is typically defined as the number of days an animal remains responsive to external stimuli. Nematodes can be propagated either in liquid media or on solid media in plates, and techniques have been developed for measuring life span under both conditions. Here we present a generalized protocol for measuring life span of nematodes maintained on solid nematode growth media and fed a diet of UV-killed bacteria. These procedures can easily be adapted to assay life span under various common conditions, including a diet consisting of live bacteria, dietary restriction, and RNA interference.

Measuring Caenorhabditis elegans Life Span on Solid Media

In this article we present a general protocol for measuring life span of nematodes maintained on solid media with UV-killed bacterial food.

Aging is a degenerative process characterized by a progressive deterioration of cellular components and organelles resulting in mortality. The nematode ...

Synthesis and Calibration of Phosphorescent Nanoprobes for Oxygen Imaging in Biological Systems

Oxygen measurement by phosphorescence quenching [1, 2] consists of the following steps: 1) the probe is delivered into the medium of interest (e.g. blood or interstitial fluid); 2) the object is illuminated with light of appropriate wavelength in order to excite the probe into its triplet state; 3) the emitted phosphorescence is collected, and its time course is analyzed to yield the phosphorescence lifetime, which is converted into the oxygen concentration (or partial pressure, pO2). The probe must not interact with the biological environment and in some cases to be 4) excreted from the medium upon the measurement completion. Each of these steps imposes requirements on the molecular design of the phosphorescent probes, which constitute the only invasive component of the measurement protocol. Here we review the design of dendritic phosphorescent nanosensors for oxygen measurements in biological systems. The probes consist of Pt or Pd porphyrin-based polyarylglycine (AG) dendrimers, modified peripherally with polyethylene glycol (PEG's) residues. For effective two-photon excitation, termini of the dendrimers may be modified with two-photon antenna chromophores, which capture the excitation energy and channel it to the triplet cores of the probes via intramolecular FRET (F&ouml;rster Resonance Energy Transfer). We describe the key photophysical properties of the probes and present detailed calibration protocols.

We present principles of oxygen measurements by phosphorescence quenching and review design of porphyrin-based dendritic nanosensors for oxygen imaging in biological systems.

Oxygen measurement by phosphorescence quenching [1, 2] consists of the following steps: 1) the probe is delivered into the medium of interest (e.g. blood ...

Using the GELFREE 8100 Fractionation System for Molecular Weight-Based Fractionation with Liquid Phase Recovery

The GELFREE 8100 Fractionation System is a novel protein fractionation system designed to maximize protein recovery during molecular weight based fractionation. The system is comprised of single-use, 8-sample capacity cartridges and a benchtop GELFREE Fractionation Instrument. During separation, a constant voltage is applied between the anode and cathode reservoirs, and each protein mixture is electrophoretically driven from a loading chamber into a specially designed gel column gel. Proteins are concentrated into a tight band in a stacking gel, and separated based on their respective electrophoretic mobilities in a resolving gel. As proteins elute from the column, they are trapped and concentrated in liquid phase in the collection chamber, free of the gel. The instrument is then paused at specific time intervals, and fractions are collected using a pipette. This process is repeated until all desired fractions have been collected. If fewer than 8 samples are run on a cartridge, any unused chambers can be used in subsequent separations.
This novel technology facilitates the quick and simple separation of up to 8 complex protein mixtures simultaneously, and offers several advantages when compared to previously available fractionation methods. This system is capable of fractionating up to 1mg of total protein per channel, for a total of 8mg per cartridge. Intact proteins over a broad mass range are separated on the basis of molecular weight, retaining important physiochemical properties of the analyte. The liquid phase entrapment provides for high recovery while eliminating the need for band or spot cutting, making the fractionation process highly reproducible1.

The accompanying video describes the use of the GELFREE 8100 Fractionation System, which partitions complex protein samples on the basis of molecular weight and recovers the fractions in liquid phase. The video describes how the technology works, how it is used, and provides resultant data, with polyacrylamide gel electrophoresis analysis of fractionated bovine liver homogenate.

The GELFREE 8100 Fractionation System is a novel protein fractionation system designed to maximize protein recovery during molecular weight based ...

Solid Plate-based Dietary Restriction in Caenorhabditis elegans

Reduction of food intake without malnutrition or starvation is known to increase lifespan and delay the onset of various age-related diseases in a wide range of species, including mammals. It also causes a decrease in body weight and fertility, as well as lower levels of plasma glucose, insulin, and IGF-1 in these animals. This treatment is often referred to as dietary restriction (DR) or caloric restriction (CR). The nematode Caenorhabditis elegans has emerged as an important model organism for studying the biology of aging. Both environmental and genetic manipulations have been used to model DR and have shown to extend lifespan in C. elegans. However, many of the reported DR studies in C. elegans were done by propagating animals in liquid media, while most of the genetic studies in the aging field were done on the standard solid agar in petri plates. Here we present a DR protocol using standard solid NGM agar-based plate with killed bacteria.

Solid Plate-based Dietary Restriction in Caenorhabditis elegans

Here we present a protocol for performing solid plate-based dietary restriction in C. elegans with killed bacteria.

Reduction of food intake without malnutrition or starvation is known to increase lifespan and delay the onset of various age-related diseases in a wide ...

Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting

To ensure the quality of animal models used in biomedical research we have developed a number of diagnostic testing strategies and methods to determine if animals have been exposed to adventitious infectious agents (viruses, mycoplasma, and other fastidious microorganisms). Infections of immunocompetent animals are generally transient, yet serum antibody responses to infection often can be detected within days to weeks and persist throughout the life of the host. Serology is the primary diagnostic methodology by which laboratory animals are monitored. Historically the indirect enzyme-linked immunosorbent assay (ELISA) has been the main screening method for serosurveillance. The ELISA is performed as a singleplex, in which one microbial antigen-antibody reaction is measured per well. In comparison the MFIA is performed as a multiplexed assay. Since the microspheres come in 100 distinct color sets, as many as 100 different assays can be performed simultaneously in a single microplate well. This innovation decreases the amount of serum, reagents and disposables required for routine testing while increasing the amount of information obtained from a single test well. In addition, we are able to incorporate multiple internal control beads to verify sample and system suitability and thereby assure the accuracy of results. These include tissue control and IgG anti-test serum species immunoglobulin (&alpha;Ig) coated bead sets to evaluate sample suitability. As in the ELISA and IFA, the tissue control detects non-specific binding of serum immunoglobulin. The &alpha;Ig control (Serum control) confirms that serum has been added and contains a sufficient immunoglobulin concentration while the IgG control bead (System Suitability control), coated with serum species immunoglobulin, demonstrates that the labeled reagents and Luminex reader are functioning properly.

Using Luminex Corporation&#x2019;s xMAP microsphere technology, we have developed the Multiplexed Fluorometric ImmunoAssay (MFIA) for serosurveillance of various laboratory animal species. The MFIA is a suspension microarray where antigen, tissue control or immunoglobulins are covalently linked to color-coded polystyrene microspheres. The MFIA testing method as well as various troubleshooting topics is addressed.

To ensure the quality of animal models used in biomedical research we have developed a number of diagnostic testing strategies and methods to determine if ...

A Liquid Phase Affinity Capture Assay Using Magnetic Beads to Study Protein-Protein Interaction: The Poliovirus-Nanobody Example

In this article, a simple, quantitative, liquid phase affinity capture assay is presented. Provided that one protein can be tagged and another protein labeled, this method can be implemented for the investigation of protein-protein interactions. It is based on one hand on the recognition of the tagged protein by cobalt coated magnetic beads and on the other hand on the interaction between the tagged protein and a second specific protein that is labeled. First, the labeled and tagged proteins are mixed and incubated at room temperature. The magnetic beads, that recognize the tag, are added and the bound fraction of labeled protein is separated from the unbound fraction using magnets. The amount of labeled protein that is captured can be determined in an indirect way by measuring the signal of the labeled protein remained in the unbound fraction. The described liquid phase affinity assay is extremely useful when conformational conversion sensitive proteins are assayed. The development and application of the assay is demonstrated for the interaction between poliovirus and poliovirus recognizing nanobodies1. Since poliovirus is sensitive to conformational conversion2 when attached to a solid surface (unpublished results), the use of ELISA is limited and a liquid phase based system should therefore be preferred. An example of a liquid phase based system often used in polioresearch3,4 is the micro protein A-immunoprecipitation test5. Even though this test has proven its applicability, it requires an Fc-structure, which is absent in the nanobodies6,7. However, as another opportunity, these interesting and stable single-domain antibodies8 can be easily engineered with different tags. The widely used (His)6-tag shows affinity for bivalent ions such as nickel or cobalt, which can on their turn be easily coated on magnetic beads. We therefore developed this simple quantitative affinity capture assay based on cobalt coated magnetic beads. Poliovirus was labeled with 35S to enable unhindered interaction with the nanobodies and to make a quantitative detection feasible. The method is easy to perform and can be established with a low cost, which is further supported by the possibility of effectively regenerating the magnetic beads.

In this article, a simple, quantitative, liquid phase affinity capture assay is presented. It is a reliable technique based on the interaction between magnetic beads and tagged proteins (e.g. nanobodies) on one hand and the affinity between the tagged protein and a second, labeled protein (e.g. poliovirus) on the other.

In this article, a simple, quantitative, liquid phase affinity capture assay is presented. Provided that one protein can be tagged and another protein ...

Dry Root Rot Disease Assays in Chickpea: a Detailed Methodology

Dry root rot (DRR) disease is an emerging biotic stress threat to chickpea cultivation around the world. It is caused by a soil-borne fungal pathogen, Rhizoctonia bataticola. In the literature, comprehensive and detailed step-by-step protocols on disease assays are sparse. This article provides complete details on the steps involved in setting up a blotting paper technique for quickly screening genotypes for resistance to DRR. The blotting paper technique is easy and less expensive. Another method, based on the sick pot approach, is a mimic of natural infection and can be applied to study the interacting components&#8212;plant, pathogen, and environment&#8212;involved in the disease triangle.
Moreover, in nature, DRR occurs mostly in rainfed chickpea cultivation areas, where soil moisture recedes as crop growth advances. Drought stress is known to predispose chickpea plants to DRR disease. Pathomorphological and molecular understanding of plant-pathogen interaction under drought stress can pave the way for the identification of elite DRR-resistant varieties from the chickpea germplasm pool. This article provides a stepwise methodology for the preparation of a sick pot and subsequent disease assay. Overall, the information presented herein will help researchers prepare R. bataticola fungal inoculum, maintain this pathogen, set up the blotting paper technique, prepare sick culture and sick pot, and assess pathogen infection in chickpea plants.

This study presents methodologies to study the pathomorphological and molecular mechanisms underlying chickpea&#8211;Rhizoctonia bataticola interaction. The blotting paper method is useful to rapidly study chickpea genotype responses, while the sick pot-based method can be used to simultaneously impose drought and R. bataticola infection and screen for tolerant genotypes.

Dry root rot (DRR) disease is an emerging biotic stress threat to chickpea cultivation around the world. It is caused by a soil-borne fungal pathogen, ...

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Spirocyclic heterocycles have recently been reported in literature to be potential drugs for cancer therapy. The synthesis of these novel orthogonal ring systems is challenging. An efficient methodology to synthesize these compounds was recently published that described the solid phase synthesis in four steps rather than the previously reported five steps. The advantage of this shorter synthesis is the elimination of the use of toxic reagents. Low-loading Regenerating Michael (REM) linker-based resin was found to be crucial in the synthesis as high-loading versions prevented the addition of reagents containing bulky phenyl and aromatic side chains. The colorimetric 3-(4&#8242;,5&#8242;-dimethylthiazol-2&#8242;-yl)-2,5- diphenyltetrazolium bromide (MTT) assay was used to examine the cytotoxicity of micromolar concentrations of these novel spirocyclic molecules in vitro. MTT is readily available commercially and produces relatively fast, reliable results, making this assay ideal for these spirocyclic heterocycles. Orthogonal ring structures as well as furfurylamine (a precursor in the synthesis method containing a similar 5-member ring motif) were tested.

Here, we describe a bioassay using 3-(4&#8242;,5&#8242;-dimethylthiazol-2&#8242;-yl)-2,5- diphenyltetrazolium bromide (MTT) to test previously synthesized spirocyclic oximes.

Spirocyclic heterocycles have recently been reported in literature to be potential drugs for cancer therapy. The synthesis of these novel orthogonal ring ...

Isolation and Analysis of Traceable and Functionalized Extracellular Vesicles from the Plasma and Solid Tissues

Circulating and tissue-resident extracellular vesicles (EVs) represent promising targets as novel theranostic biomarkers, and they emerge as important players in the maintenance of organismal homeostasis and the progression of a wide spectrum of diseases. While the current research focuses on the characterization of endogenous exosomes with the endosomal origin, microvesicles blebbing from the plasma membrane have gained increasing attention in health and sickness, which are featured by an abundance of surface molecules recapitulating the membrane signature of parent cells. Here, a reproducible procedure is presented based on differential centrifugation for extracting and characterizing EVs from the plasma and solid tissues, such as the bone. The protocol further describes subsequent profiling of surface antigens and protein cargos of EVs, which are thus traceable for their derivations and identified with components related to potential function. This method will be useful for correlative, functional, and mechanistic analysis of EVs in biological, physiological, and pathological studies.

The present protocol describes a method to extract extracellular vesicles from the peripheral blood and solid tissues with subsequent profiling of surface antigens and protein cargos.

Circulating and tissue-resident extracellular vesicles (EVs) represent promising targets as novel theranostic biomarkers, and they emerge as important ...

Determination of S-Phase Duration Using 5-Ethynyl-2'-deoxyuridine Incorporation in Saccharomyces cerevisiae

Eukaryotic DNA replication is a highly regulated process that ensures that the genetic blueprint of a cell is correctly duplicated prior to chromosome segregation. As DNA synthesis defects underlie chromosome rearrangements, monitoring DNA replication has become essential to understand the basis of genome instability. Saccharomyces cerevisiae is a classical model to study cell cycle regulation, but key DNA replication parameters, such as the fraction of cells in the S phase or the S-phase duration, are still difficult to determine. This protocol uses short and non-toxic pulses of 5-ethynyl-2'-deoxyuridine (EdU), a thymidine analog, in engineered TK-hENT1 yeast cells, followed by its detection by Click reaction to allow the visualization and quantification of DNA replication with high spatial and temporal resolution at both the single-cell and population levels by microscopy and flow cytometry. This method may identify previously overlooked defects in the S phase and cell cycle progression of yeast mutants, thereby allowing the characterization of new players essential for ensuring genome stability.

Determination of S-Phase Duration Using 5-Ethynyl-2&#039;-deoxyuridine Incorporation in Saccharomyces cerevisiae

We describe two complementary protocols to accurately determine S-phase duration in S. cerevisiae using EdU, a thymidine analog, which is incorporated in vivo and detected using Click chemistry by microscopy and flow cytometry. It allows for the easy characterization of the duration of DNA replication and overlooked replication defects in mutants.

Eukaryotic DNA replication is a highly regulated process that ensures that the genetic blueprint of a cell is correctly duplicated prior to chromosome ...